Items 1 to 10 of about 276507
1. Hull BP, Hendry AJ, Dey A, Beard FH, Brotherton JM, McIntyre PB: Immunisation coverage annual report, 2014. Commun Dis Intell Q Rep; 2017 Mar 31;41(1):E68-E90
MedlinePlus Health Information. consumer health - Immunization.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunisation coverage annual report, 2014.
  • This 8th annual immunisation coverage report shows data for 2014 derived from the Australian Childhood Immunisation Register and the National Human Papillomavirus Vaccination Program Register.
  • Overall, 'fully immunised' coverage has been mostly stable at the 12- and 24-month age milestones since late 2003, but at 60 months of age, it has increased by more than 10 percentage points since 2009.
  • As in previous years, coverage for 'fully immunised' at 12 months of age among Indigenous children was 3.7% lower than for non-Indigenous children overall, varying from 6.9 percentage points in Western Australia to 0.3 of a percentage point in the Australian Capital Territory.
  • In 2014, 73.4% of Australian females aged 15 years had 3 documented doses of human papillomavirus vaccine (jurisdictional range 67.7% to 77.4%), and 82.7% had at least 1 dose, compared with 71.4% and 81.5%, respectively, in 2013.
  • The disparity in on-time vaccination between Indigenous and non-Indigenous children in 2014 diminished progressively from 20.2% for vaccines due by 12 months to 11.5% for those due by 24 months and 3.0% at 60 months of age.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28385140.001).
  • [ISSN] 1447-4514
  • [Journal-full-title] Communicable diseases intelligence quarterly report
  • [ISO-abbreviation] Commun Dis Intell Q Rep
  • [Language] eng
  • [Publication-type] Historical Article; Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Vaccines
  •  go-up   go-down


2. Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C, Pande G, Ario AR, Matovu JK, Wanyenze RK, Kiyaga C: Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015. BMC Infect Dis; 2017 May 03;17(1):326
HIV InSite. treatment guidelines - Adherence to HIV Antiretroviral Therapy .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014-July 2015.
  • BACKGROUND: Despite the growing number of people on antiretroviral therapy (ART), there is limited information about virological non-suppression and its determinants among HIV-positive (HIV+) individuals enrolled in HIV care in many resource-limited settings.
  • METHODS: We conducted a descriptive cross-sectional study using routinely collected program data from viral load (VL) samples collected across the country for testing at the Central Public Health Laboratories (CPHL) in Uganda.
  • Data were generated between August 2014 and July 2015.
  • The overall proportion of non-suppression was 11%.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Health Popul Nutr. 2013 Jun;31(2):150-70 [23930333.001]
  • [Cites] Antivir Ther. 2009;14(2):293-7 [19430104.001]
  • [Cites] BMC Infect Dis. 2009 Jun 03;9:81 [19493344.001]
  • [Cites] AIDS. 2006 Aug 1;20(12):1605-12 [16868441.001]
  • [Cites] J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):413-9 [25559604.001]
  • [Cites] Clin Infect Dis. 2008 May 15;46(10):1589-97 [18419495.001]
  • [Cites] J Int AIDS Soc. 2013 Nov 13;16(3 Suppl 2):18640 [24242258.001]
  • [Cites] PLoS One. 2013;8(2):e55747 [23418455.001]
  • [Cites] AIDS. 2001 Jan 26;15(2):185-94 [11216926.001]
  • [Cites] J Infect Dis. 2010 Jan 1;201(1):106-13 [19938977.001]
  • [Cites] J Infect Dis. 2010 Mar;201(5):662-71 [20102271.001]
  • [Cites] Lancet Infect Dis. 2009 Jul;9(7):409-17 [19555900.001]
  • [Cites] AIDS. 2009 Jun 1;23(9):1127-34 [19417582.001]
  • [Cites] BMC Pediatr. 2008 Oct 02;8:39 [18831747.001]
  • [Cites] PLoS One. 2015 Feb 19;10(2):e0116144 [25695494.001]
  • [Cites] AIDS Educ Prev. 2003 Feb;15(1):49-69 [12627743.001]
  • [Cites] AIDS. 2008 Jul 11;22(11):1305-12 [18580610.001]
  • [Cites] Top HIV Med. 2009 Feb-Mar;17(1):14-25 [19270345.001]
  • [Cites] Pediatr Infect Dis J. 1999 Aug;18(8):682-9 [10462336.001]
  • [Cites] Trop Med Int Health. 2016 Jun;21(6):750-8 [26996396.001]
  • [Cites] Drugs. 2012 Jun 18;72(9):e1-25 [22686620.001]
  • [Cites] PLoS One. 2013;8(2):e55824 [23418463.001]
  • [Cites] AIDS Behav. 2006 Sep;10(5):473-82 [16604295.001]
  • [Cites] AIDS. 2000 Mar 31;14(5):499-507 [10780712.001]
  • [Cites] AIDS. 2010 Jul 17;24(11):1679-87 [20453629.001]
  • [Cites] Int J STD AIDS. 2011 Nov;22(11):659-64 [22096052.001]
  • [Cites] HIV Med. 2010 Sep;11(8):510-8 [20345885.001]
  • [Cites] AIDS. 2010 Jul 31;24(12):1849-55 [20622529.001]
  • [Cites] Clin Infect Dis. 2009 Jul 15;49(2):306-9 [19522657.001]
  • [Cites] J Adolesc Health. 2010 Nov;47(5):504-11 [20970086.001]
  • [Cites] Bull World Health Organ. 2013 May 1;91(5):377-385E [23678201.001]
  • [Cites] J Antimicrob Chemother. 2004 Jan;53(1):95-101 [14657091.001]
  • [Cites] AIDS. 2008 Oct 1;22(15):1971-7 [18784460.001]
  • [Cites] PLoS One. 2015 May 26;10(5):e0127235 [26011158.001]
  • (PMID = 28468608.001).
  • [ISSN] 1471-2334
  • [Journal-full-title] BMC infectious diseases
  • [ISO-abbreviation] BMC Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Antiretroviral therapy / Uganda / Virological non-suppression
  •  go-up   go-down


3. Lee EK, Kang HM, Song BM, Lee YN, Heo GB, Lee HS, Lee YJ, Kim JH: Surveillance of avian influenza viruses in South Korea between 2012 and 2014. Virol J; 2017 Mar 14;14(1):54

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surveillance of avian influenza viruses in South Korea between 2012 and 2014.
  • In this study, we report on a nationwide surveillance study of AIV in domestic poultry and wild birds in South Korea between 2012 and 2014.
  • METHODS: During the surveillance programs between 2012 and 2014, 141,560 samples were collected.
  • Of these, 102,199 were from poultry farms, 8215 were from LBMs, and 31,146 were from wild bird habitats.
  • RESULTS: Between 2012 and 2014, a total of 819 AIV were isolated from 141,560 samples.
  • Virus isolation rates for AIV were 0.6, 0.4, 0.1, and 2.7% in wild birds (n = 202), domestic ducks (n = 387), minor poultry (n = 11), and the live bird market (LBM) (n = 219), respectively.
  • The major subtypes were H5 (n = 48, 23.9%: N3 (n = 4) and N8 (n = 44)), H4 (n = 39, 19.4%), and H1 (n = 29, 14.4%).
  • In domestic poultry, mainly ducks, the H5N8 (n = 275, 59.3%), H3 (n = 30, 17.2%), and H6 (n = 53, 11.4%) subtypes were predominantly found.
  • The unusual high prevalence of the H5 subtype of AIV was due to the large scale outbreak of H5N8 HPAI in wild birds and domestic poultry in 2014.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Gen Virol. 2015 May;96(Pt 5):975-81 [25604926.001]
  • [Cites] PLoS One. 2014 Apr 28;9(4):e91887 [24776918.001]
  • [Cites] Emerg Infect Dis. 2008 Mar;14(3):487-90 [18325269.001]
  • [Cites] Sci China Life Sci. 2014 Jul;57(7):731-2 [24907936.001]
  • [Cites] J Vet Sci. 2010 Jun;11(2):161-3 [20458158.001]
  • [Cites] Virus Res. 2013 Dec 5;178(1):63-77 [23735535.001]
  • [Cites] J Gen Virol. 2012 Jun;93(Pt 6):1278-87 [22422062.001]
  • [Cites] Vet Microbiol. 2010 Mar 24;141(3-4):362-6 [19800184.001]
  • [Cites] Vet Microbiol. 2012 Mar 23;155(2-4):147-57 [21955449.001]
  • [Cites] Vet Rec. 2006 Mar 11;158(10):341-4 [16531583.001]
  • [Cites] Mol Biol Evol. 2013 Dec;30(12):2725-9 [24132122.001]
  • [Cites] Science. 2015 Feb 6;347(6222):616-7 [25657235.001]
  • [Cites] J Virol. 2015 Jun;89(12):6521-4 [25855748.001]
  • [Cites] Infect Genet Evol. 2015 Aug;34:267-77 [26079277.001]
  • [Cites] Avian Dis. 2010 Mar;54(1 Suppl):738-48 [20521725.001]
  • [Cites] Virology. 1999 Aug 15;261(1):15-9 [10484749.001]
  • [Cites] Emerg Infect Dis. 2015 May;21(5):886-90 [25898265.001]
  • [Cites] Arch Virol. 2001 Dec;146(12):2275-89 [11811679.001]
  • [Cites] J Virol. 2005 Mar;79(5):2814-22 [15709000.001]
  • [Cites] J Gen Virol. 2010 Jan;91(Pt 1):208-19 [19812266.001]
  • [Cites] J Wildl Dis. 2010 Jul;46(3):878-88 [20688693.001]
  • [Cites] Emerg Infect Dis. 2012 Mar;18(3):480-3 [22377052.001]
  • [Cites] Sci Rep. 2015 Jan 15;5:7632 [25591167.001]
  • [Cites] Emerg Infect Dis. 2014 Jun;20(6):1087-9 [24856098.001]
  • [Cites] Vet Microbiol. 2014 Oct 10;173(3-4):249-57 [25192767.001]
  • [Cites] Virology. 2007 Mar 15;359(2):313-23 [17056087.001]
  • (PMID = 28292308.001).
  • [ISSN] 1743-422X
  • [Journal-full-title] Virology journal
  • [ISO-abbreviation] Virol. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Avian influenza virus / Domestic poultry / LBM / Surveillance / Wild bird
  •  go-up   go-down


4. Ma S, Wan X, Deng Z, Shi L, Hao C, Zhou Z, Zhou C, Fang Y, Liu J, Yang J, Chen X, Li T, Zang A, Yin S, Li B, Plumas J, Chaperot L, Zhang X, Xu G, Jiang L, Shen N, Xiong S, Gao X, Zhang Y, Xiao H: Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs. J Exp Med; 2017 May 01;214(5):1471-1491
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs.
  • TLR7/9 signals are capable of mounting massive interferon (IFN) response in plasmacytoid dendritic cells (pDCs) immediately after viral infection, yet the involvement of epigenetic regulation in this process has not been documented.
  • Here, we report that zinc finger CXXC family epigenetic regulator CXXC5 is highly expressed in pDCs, where it plays a crucial role in TLR7/9- and virus-induced IFN response.
  • Notably, genetic ablation of CXXC5 resulted in aberrant methylation of the CpG-containing island (CGI) within the <i>Irf7</i> gene and impaired IRF7 expression in steady-state pDCs.
  • Mechanistically, CXXC5 is responsible for the recruitment of DNA demethylase Tet2 to maintain the hypomethylation of a subset of CGIs, a process coincident with active histone modifications and constitutive transcription of these CGI-containing genes.
  • Consequently, CXXC5-deficient mice had compromised early IFN response and became highly vulnerable to infection by herpes simplex virus and vesicular stomatitis virus.
  • Together, our results identify CXXC5 as a novel epigenetic regulator for pDC-mediated antiviral response.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Ma et al.
  • [Cites] J Leukoc Biol. 2016 Aug;100(2):327-38 [26896487.001]
  • [Cites] Virol Sin. 2015 Jun;30(3):174-89 [26122641.001]
  • [Cites] Nature. 2015 Sep 17;525(7569):389-93 [26287468.001]
  • [Cites] Annu Rev Immunol. 2011;29:163-83 [21219184.001]
  • [Cites] J Biol Chem. 2000 Oct 13;275(41):31805-12 [10924517.001]
  • [Cites] J Virol. 2016 Oct 28;90(22):10050-10053 [27605675.001]
  • [Cites] Mol Cell. 2013 Aug 8;51(3):310-25 [23932714.001]
  • [Cites] Nat Immunol. 2008 Oct;9(10):1157-64 [18758466.001]
  • [Cites] Nat Rev Immunol. 2015 Aug;15(8):471-85 [26160613.001]
  • [Cites] J Immunol. 2007 May 1;178(9):5839-47 [17442968.001]
  • [Cites] Annu Rev Immunol. 2013;31:563-604 [23516985.001]
  • [Cites] Mol Cell. 2014 Jun 5;54(5):844-57 [24813947.001]
  • [Cites] Nat Rev Immunol. 2013 Aug;13(8):566-77 [23827956.001]
  • [Cites] Cell Stem Cell. 2014 Apr 3;14(4):512-22 [24529596.001]
  • [Cites] Nat Rev Immunol. 2011 Jul 22;11(8):558-65 [21779033.001]
  • [Cites] Nat Immunol. 2015 Jun;16(6):642-52 [25915733.001]
  • [Cites] Immunity. 2015 Apr 21;42(4):613-26 [25862091.001]
  • [Cites] Cold Spring Harb Perspect Biol. 2013 Nov 01;5(11):a018648 [24186071.001]
  • [Cites] Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3012-7 [22315415.001]
  • [Cites] J Exp Med. 2009 Aug 31;206(9):1983-94 [19703986.001]
  • [Cites] J Exp Med. 2014 Sep 22;211(10):1977-91 [25180065.001]
  • [Cites] Nat Immunol. 2005 Oct;6(10 ):981-8 [16127453.001]
  • [Cites] Nat Immunol. 2012 Sep;13(9):888-99 [22797772.001]
  • [Cites] Immunity. 2000 Oct;13(4):539-48 [11070172.001]
  • [Cites] Cold Spring Harb Perspect Biol. 2012 Aug 01;4(8):a007401 [22855722.001]
  • [Cites] Immunity. 2011 Dec 23;35(6):958-71 [22177923.001]
  • [Cites] J Biol Chem. 2009 Feb 6;284(6):3672-81 [19001364.001]
  • [Cites] Cold Spring Harb Perspect Biol. 2014 May 01;6(5):a019133 [24789823.001]
  • [Cites] Genes Immun. 2011 Sep;12(6):399-414 [21490621.001]
  • [Cites] J Immunol. 2006 Jan 1;176(1):248-55 [16365416.001]
  • [Cites] Nat Immunol. 2004 Oct;5(10):1061-8 [15361868.001]
  • [Cites] Immunity. 2014 May 15;40(5):642-56 [24837101.001]
  • [Cites] Eur J Haematol. 2013 Mar;90(3):259-60 [23190153.001]
  • [Cites] Cell. 2013 Feb 28;152(5):1146-59 [23434322.001]
  • [Cites] Cell Host Microbe. 2013 Jun 12;13(6):652-64 [23768490.001]
  • [Cites] Immunity. 2003 Dec;19(6):903-12 [14670306.001]
  • [Cites] Nature. 2013 May 2;497(7447):122-6 [23563267.001]
  • [Cites] Immunity. 2010 Dec 14;33(6):905-16 [21145760.001]
  • [Cites] Blood. 2009 Apr 2;113(14):3172-81 [19182210.001]
  • [Cites] J Immunol. 2000 Mar 15;164(6):2978-86 [10706685.001]
  • [Cites] Immunol Rev. 2015 Jan;263(1):6-21 [25510268.001]
  • [Cites] J Exp Med. 2014 Sep 22;211(10):1969-76 [25180061.001]
  • [Cites] Genome Biol. 2013;14(10):R119 [24156278.001]
  • [Cites] Immunity. 2015 Aug 18;43(2):251-63 [26275994.001]
  • [Cites] Nature. 2007 Oct 4;449(7162):564-9 [17873860.001]
  • [Cites] Nature. 2006 Apr 13;440(7086):949-53 [16612387.001]
  • [Cites] Sci China C Life Sci. 2009 Jun;52(6):528-38 [19557330.001]
  • [Cites] Epigenetics. 2011 Feb;6(2):147-52 [20935486.001]
  • [Cites] Mol Cell. 2011 May 20;42(4):451-64 [21514197.001]
  • [Cites] J Immunol. 2002 May 1;168(9):4796-801 [11971031.001]
  • [Cites] Cell. 2012 Dec 7;151(6):1200-13 [23217707.001]
  • [Cites] J Leukoc Biol. 2003 Dec;74(6):1125-38 [12960254.001]
  • [Cites] Nature. 2011 Sep 04;477(7366):606-10 [21892189.001]
  • [Cites] Blood. 2012 Nov 22;120(22):4363-73 [23033267.001]
  • [Cites] J Immunol. 2006 Dec 1;177(11):7510-4 [17114418.001]
  • [Cites] J Clin Invest. 2015 Sep;125(9):3692-703 [26301812.001]
  • [Cites] J Clin Immunol. 2004 Nov;24(6):637-46 [15622448.001]
  • [Cites] Elife. 2012 Dec 18;1:e00205 [23256043.001]
  • [Cites] PLoS Pathog. 2012 Sep;8(9):e1002915 [23028315.001]
  • [Cites] Nature. 2005 Apr 7;434(7034):772-7 [15800576.001]
  • [Cites] J Immunol. 2014 Dec 15;193(12):5772-8 [25480956.001]
  • [Cites] Cell. 2009 Jul 10;138(1):114-28 [19596239.001]
  • [Cites] Cell Death Differ. 2015 Jun;22(6):912-20 [25633194.001]
  • [Cites] Glia. 2016 Mar;64(3):350-62 [26462610.001]
  • [Cites] J Exp Med. 2007 Oct 1;204(10):2423-37 [17893202.001]
  • [Cites] PLoS Pathog. 2013 Oct;9(10):e1003728 [24204273.001]
  • [Cites] Biochem Soc Trans. 2013 Jun;41(3):727-40 [23697932.001]
  • [Cites] Genome Biol. 2008 Jan 24;9(1):R17 [18218067.001]
  • [Cites] Blood. 2009 Aug 27;114(9):1794-802 [19553637.001]
  • [Cites] J Immunol. 1999 Aug 1;163(3):1529-36 [10415056.001]
  • [Cites] J Exp Med. 2015 Jun 29;212(7):1061-80 [26056233.001]
  • [Cites] Science. 2015 Apr 24;348(6233):448-53 [25814066.001]
  • [Cites] J Biol Chem. 2010 May 7;285(19):14585-93 [20220130.001]
  • [Cites] PLoS Pathog. 2014 Jul 31;10(7):e1004291 [25077616.001]
  • [Cites] J Exp Med. 2006 May 15;203(5):1153-9 [16682497.001]
  • [Cites] Annu Rev Immunol. 2014;32:489-511 [24555473.001]
  • [Cites] Immunity. 2010 Dec 14;33(6):955-66 [21130004.001]
  • (PMID = 28416650.001).
  • [ISSN] 1540-9538
  • [Journal-full-title] The Journal of experimental medicine
  • [ISO-abbreviation] J. Exp. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. DeForte S, Reddy KD, Uversky VN: Quarterly intrinsic disorder digest (January-February-March, 2014). Intrinsically Disord Proteins; 2016;4(1):e1153395

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quarterly intrinsic disorder digest (January-February-March, 2014).
  • The current digest issue covers papers published during the first quarter of 2014; i.e., during the period of January, February, and March of 2014.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Cell. 2014 Feb 6;53(3):433-43 [24412063.001]
  • [Cites] Hum Mol Genet. 2014 Jan 1;23(1):157-70 [23962724.001]
  • [Cites] Bioessays. 2014 Feb;36(2):209-18 [24272815.001]
  • [Cites] Structure. 2014 Feb 4;22(2):177-8 [24507778.001]
  • [Cites] RNA. 2014 Mar;20(3):321-30 [24442609.001]
  • [Cites] Elife. 2014;3:e01584 [24497545.001]
  • [Cites] J Phys Chem B. 2014 Mar 20;118(11):3018-25 [24571104.001]
  • [Cites] Chaos. 2014 Mar;24(1):013103 [24697365.001]
  • [Cites] Prion. 2014 Jan-Feb;8(1):19-32 [24552879.001]
  • [Cites] Nucleic Acids Res. 2014 Jan;42(2):1311-25 [24121686.001]
  • [Cites] FEBS Lett. 2014 Jan 31;588(3):497-502 [24374342.001]
  • [Cites] J Mol Biol. 2014 Jan 9;426(1):62-70 [24120941.001]
  • [Cites] Protein Expr Purif. 2014 Jan;93:23-31 [24161561.001]
  • [Cites] Biosci Biotechnol Biochem. 2014;78(11):1864-70 [25052097.001]
  • [Cites] Biophys J. 2014 Feb 18;106(4):865-74 [24559989.001]
  • [Cites] J Phys Chem B. 2014 Jan 9;118(1):134-43 [24350625.001]
  • [Cites] Methods Mol Biol. 2014;1091:3-16 [24203321.001]
  • [Cites] Cytoskeleton (Hoboken). 2014 Mar;71(3):170-83 [24415668.001]
  • [Cites] Wiley Interdiscip Rev RNA. 2014 Jan-Feb;5(1):95-110 [24217978.001]
  • [Cites] Biochemistry. 2014 Mar 18;53(10 ):1657-69 [24506136.001]
  • [Cites] Chem Commun (Camb). 2014 Feb 11;50(12):1488-90 [24366473.001]
  • [Cites] Nucleic Acids Res. 2014 Feb;42(4):2112-25 [24253305.001]
  • [Cites] Nucleic Acids Res. 2014 Jan;42(Database issue):D320-5 [24178034.001]
  • [Cites] Drug Dev Res. 2014 Feb;75(1):10-22 [24648045.001]
  • [Cites] J Biomol Struct Dyn. 2014;32(2):257-72 [23527530.001]
  • [Cites] FEBS Lett. 2014 Jan 21;588(2):236-46 [24211444.001]
  • [Cites] Neurodegener Dis. 2014;13(2-3):114-7 [24192542.001]
  • [Cites] Biochim Biophys Acta. 2014 Mar;1840(3):993-1003 [24211251.001]
  • [Cites] Structure. 2014 Feb 4;22(2):238-49 [24361273.001]
  • [Cites] Biochemistry. 2014 Jan 21;53(2):293-9 [24367999.001]
  • [Cites] Angew Chem Int Ed Engl. 2014 Feb 3;53(6):1548-51 [24449148.001]
  • [Cites] Faraday Discuss. 2014;169:179-93 [25340810.001]
  • [Cites] Proteins. 2014 Feb;82 Suppl 2:127-37 [23946100.001]
  • [Cites] Protein Pept Lett. 2014;21(12):1265-72 [25001212.001]
  • [Cites] Nucleic Acids Res. 2007 Jan;35(Database issue):D786-93 [17145717.001]
  • [Cites] J Biomol Struct Dyn. 2014;32(3):448-64 [23534882.001]
  • [Cites] J Biomol NMR. 2014 Mar;58(3):175-92 [24496557.001]
  • [Cites] Chem Rev. 2014 Mar 26;114(6):3281-317 [24432838.001]
  • [Cites] Proteins. 2014 Jan;82(1):145-58 [23798504.001]
  • [Cites] Mol Endocrinol. 2014 Feb;28(2):173-82 [24284822.001]
  • [Cites] J Neurosci. 2014 Jan 22;34(4):1325-32 [24453323.001]
  • [Cites] Biochim Biophys Acta. 2014 Jan;1843(1):216-21 [23684952.001]
  • [Cites] Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4097-102 [24591642.001]
  • [Cites] J Biomol Struct Dyn. 2014;32(11):1817-32 [24028075.001]
  • [Cites] J Biol Chem. 2014 Feb 28;289(9):5528-33 [24421312.001]
  • [Cites] Nucleic Acids Res. 2013 Jan;41(Database issue):D508-16 [23203878.001]
  • [Cites] Biochim Biophys Acta. 2014 Jan;1843(1):103-13 [23557784.001]
  • [Cites] Biochim Biophys Acta. 2014 Feb;1844(2):346-57 [24252314.001]
  • [Cites] BMC Bioinformatics. 2013;14 Suppl 7:S3 [23815411.001]
  • [Cites] Nucleic Acids Res. 2014 Jan;42(2):1162-79 [24165877.001]
  • [Cites] Biochem Biophys Res Commun. 2014 Jan 24;443(4):1251-6 [24406167.001]
  • [Cites] Biochemistry. 2014 Mar 18;53(10):1670-9 [24559171.001]
  • [Cites] Mol Biosyst. 2012 Jan;8(1):327-37 [22009164.001]
  • [Cites] Nucleic Acids Res. 2014 Jan;42(Database issue):D222-30 [24288371.001]
  • [Cites] Biochemistry. 2014 Mar 18;53(10):1680-96 [24559112.001]
  • [Cites] Biochem J. 2014 Feb 15;458(1):109-18 [24266766.001]
  • [Cites] Phys Rev E Stat Nonlin Soft Matter Phys. 2014 Feb;89(2):022723 [25353524.001]
  • [Cites] Nat Commun. 2014;5:3139 [24457896.001]
  • [Cites] J Biomol NMR. 2014 Mar;58(3):193-207 [24515886.001]
  • [Cites] Structure. 2014 Feb 4;22(2):250-9 [24373767.001]
  • [Cites] J Struct Biol. 2014 Feb;185(2):168-77 [23537847.001]
  • [Cites] Curr Pharm Des. 2014;20(8):1274-92 [23713779.001]
  • [Cites] Biopolymers. 2014 Jan;102(1):69-77 [24037535.001]
  • [Cites] Biochemistry. 2014 Mar 11;53(9):1466-76 [24506064.001]
  • [Cites] Nucleic Acids Res. 2014 Jan;42(Database issue):D326-35 [24174539.001]
  • [Cites] Nucleic Acids Res. 2014 Jan;42(Database issue):D273-8 [24150944.001]
  • [Cites] Angew Chem Int Ed Engl. 2014 Jan 20;53(4):1025-8 [24338988.001]
  • [Cites] J Mol Biol. 2014 Mar 20;426(6):1322-50 [24184279.001]
  • [Cites] Protein Expr Purif. 2014 Mar;95:113-20 [24333369.001]
  • [Cites] J Biomol NMR. 2014 Feb;58(2):129-39 [24435565.001]
  • [Cites] Proc Natl Acad Sci U S A. 2014 Feb 25;111(8):E768-75 [24516125.001]
  • [Cites] J Biomol NMR. 2014 Jan;58(1):49-60 [24346685.001]
  • [Cites] Cell. 2014 Feb 27;156(5):963-74 [24581495.001]
  • [Cites] J Phys Chem B. 2014 Jan 16;118(2):501-10 [24372615.001]
  • [Cites] Cell Cycle. 2014;13(23):3768-82 [25483085.001]
  • [Cites] J Mol Biol. 2014 Jan 9;426(1):21-35 [24055379.001]
  • [Cites] Biophys J. 2014 Feb 4;106(3):556-65 [24507596.001]
  • [Cites] Adv Exp Med Biol. 2014;805:331-51 [24446368.001]
  • [Cites] FEBS Lett. 2014 Jan 21;588(2):247-52 [24076468.001]
  • [Cites] Cancer Res. 2014 Feb 15;74(4):1250-60 [24371229.001]
  • [Cites] Nucleic Acids Res. 2014 Jan;42(2):1180-95 [24106084.001]
  • [Cites] Infect Genet Evol. 2014 Jan;21:424-35 [24384095.001]
  • [Cites] Curr Protein Pept Sci. 2014;15(8):778-97 [25245670.001]
  • [Cites] J Cell Sci. 2014 Jan 1;127(Pt 1):124-36 [24144701.001]
  • [Cites] J Am Chem Soc. 2014 Mar 12;136(10):3803-16 [24559475.001]
  • [Cites] Curr Top Membr. 2014;73:69-148 [24745981.001]
  • [Cites] J Biol Chem. 2014 Feb 7;289(6):3652-65 [24338013.001]
  • [Cites] Protein Pept Lett. 2014 Mar;21(3):247-55 [24370255.001]
  • [Cites] Annu Rev Biochem. 2014;83:553-84 [24606139.001]
  • [Cites] Anal Biochem. 2014 Mar 15;449:17-25 [24333248.001]
  • [Cites] Biochemistry. 2014 Jan 21;53(2):279-81 [24397337.001]
  • [Cites] Chem Soc Rev. 2014 Feb 21;43(4):1172-88 [24336839.001]
  • [Cites] Biochim Biophys Acta. 2014 Feb;1842(2):154-63 [24263171.001]
  • [Cites] Antiviral Res. 2014 Mar;103:39-50 [24418573.001]
  • (PMID = 28232896.001).
  • [ISSN] 2169-0693
  • [Journal-full-title] Intrinsically disordered proteins
  • [ISO-abbreviation] Intrinsically Disord Proteins
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; database / intrinsically disordered proteins / protein function / structural ensemble / structural proteins
  •  go-up   go-down


6. Bynum JA, Wang X, Stavchansky SA, Bowman PD: Time Course Expression Analysis of 1[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole Induction of Cytoprotection in Human Endothelial Cells. Gene Regul Syst Bio; 2017;11:1177625017701106

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Time Course Expression Analysis of 1[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole Induction of Cytoprotection in Human Endothelial Cells.
  • 1[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im), a synthetic derivative of oleanolic acid that exhibits antioxidant and anti-inflammatory activity in several animal and in vitro models, has been shown to be beneficial if given after injury.
  • Time-course gene expression profiling was performed on HUVEC treated with CDDO-Im for 0.5, 1, 3, 6, and 24 hours.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Antioxid Redox Signal. 2007 Nov;9(11):1963-70 [17822364.001]
  • [Cites] Bioinformatics. 2010 Nov 15;26(22):2927-8 [20926419.001]
  • [Cites] PLoS One. 2014 Jun 24;9(6):e100862 [24959884.001]
  • [Cites] Nucleic Acids Res. 2013 Jul;41(Web Server issue):W115-22 [23794635.001]
  • [Cites] Proc Natl Acad Sci U S A. 1995 May 9;92(10):4337-41 [7753808.001]
  • [Cites] Behav Brain Res. 2012 Nov 1;235(1):67-72 [22820234.001]
  • [Cites] Cancer Res. 1999 Jan 15;59(2):336-41 [9927043.001]
  • [Cites] Curr Opin Pharmacol. 2011 Oct;11(5):549-56 [21752712.001]
  • [Cites] PLoS One. 2013 May 31;8(5):e63798 [23741300.001]
  • [Cites] J Biol Chem. 2000 Dec 1;275(48):37303-6 [11018021.001]
  • [Cites] Brain Struct Funct. 2014 Jan;219(1):415-30 [23389809.001]
  • [Cites] Eur J Pharmacol. 2008 Sep 4;591(1-3):28-35 [18573251.001]
  • [Cites] Biotechnol Lett. 2006 Oct;28(19):1601-13 [16900335.001]
  • [Cites] Pharmacology. 2015 ;95(3-4):181-92 [25926128.001]
  • [Cites] Eur J Pharmacol. 2014 Jul 5;734:122-31 [24703885.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):250-5 [19104057.001]
  • [Cites] Biosystems. 2014 Oct;124:75-85 [25199502.001]
  • [Cites] J Biol Chem. 2013 Nov 22;288(47):33966-77 [24126911.001]
  • [Cites] J Mol Med (Berl). 1999 Jun;77(6):469-80 [10475062.001]
  • [Cites] Toxicol Appl Pharmacol. 2009 Apr 1;236(1):109-14 [19371629.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2014 Feb;306(3):G218-28 [24309183.001]
  • [Cites] Toxicol Lett. 2010 Nov 10;199(1):43-50 [20708668.001]
  • [Cites] Molecules. 2013 Mar 13;18(3):3250-65 [23486104.001]
  • [Cites] Am J Respir Crit Care Med. 2009 Nov 1;180(9):867-74 [19679692.001]
  • [Cites] Nature. 1977 Jun 2;267(5610):423-5 [876356.001]
  • [Cites] Biochemistry (Mosc). 2013 Feb;78(2):111-26 [23581983.001]
  • [Cites] J Biol Chem. 1998 May 22;273(21):13280-8 [9582373.001]
  • [Cites] Physiol Genomics. 2014 Oct 15;46(20):779-87 [25159852.001]
  • [Cites] Eur J Immunol. 2005 Oct;35(10):2991-3001 [16184516.001]
  • [Cites] Cancers (Basel). 2010 Dec;2(4):1779-93 [21799944.001]
  • [Cites] Biochem Biophys Res Commun. 2012 Jun 15;422(4):561-7 [22609405.001]
  • [Cites] Bioinformatics. 2012 Jan 1;28(1):105-11 [22080467.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2274-9 [16461893.001]
  • [Cites] J Biol Chem. 2002 Apr 26;277(17 ):14884-93 [11842088.001]
  • [Cites] Cancer Prev Res (Phila). 2011 Mar;4(3):425-34 [21372041.001]
  • [Cites] AAPS J. 2013 Apr;15(2):427-37 [23319288.001]
  • [Cites] J Exp Med. 2006 Jan 23;203(1):15-20 [16380512.001]
  • [Cites] BMC Res Notes. 2010 Jul 17;3:201 [20637119.001]
  • [Cites] Kidney Int. 2014 Jan;85(1):134-41 [24088953.001]
  • [Cites] Genome Biol. 2008;9 Suppl 1:S4 [18613948.001]
  • [Cites] Cancer Inform. 2007 Feb 04;3:11-7 [19455231.001]
  • [Cites] Stroke. 2012 May;43(5):1390-7 [22461332.001]
  • [Cites] Radiat Res. 2010 Jul;174(1):27-36 [20681796.001]
  • [Cites] Science. 1999 Jan 1;283(5398):83-7 [9872747.001]
  • [Cites] Cancer Prev Res (Phila). 2012 Jan;5(1):89-97 [21933912.001]
  • (PMID = 28469413.001).
  • [Journal-full-title] Gene regulation and systems biology
  • [ISO-abbreviation] Gene Regul Syst Bio
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; CDDO-IM / Microarray / cytoprotection / time-course gene expression
  •  go-up   go-down


7. Sakata M, Ishibashi K, Imai M, Wagatsuma K, Ishii K, Hatano K, Ishiwata K, Toyohara J: Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [&lt;sup&gt;11&lt;/sup&gt;C]CB184, in healthy human volunteers. EJNMMI Res; 2017 Dec;7(1):26

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [<sup>11</sup>C]CB184, in healthy human volunteers.
  • BACKGROUND: N,N-di-n-propyl-2-[2-(4-[<sup>11</sup>C]methoxyphenyl)-6,8-dichloroimidazol[1,2-a]pyridine-3-yl]acetamide ([<sup>11</sup>C]CB184) is a novel selective radioligand for the 18-kD translocator protein (TSPO), which is upregulated in activated microglia in the brain, and may be useful in positron emission tomography (PET).
  • We examined the safety, radiation dosimetry, and initial brain imaging with [<sup>11</sup>C]CB184 in healthy human volunteers.
  • RESULTS: Dynamic [<sup>11</sup>C]CB184 PET scans (90 min) were performed in five healthy male subjects.
  • [<sup>11</sup>C]CB184 was metabolized in the periphery: 36.7% ± 5.7% of the radioactivity in plasma was detected as the unchanged form after 60 min.
  • The V <sub>T</sub> of [<sup>11</sup>C]CB184 was highest in the thalamus (5.1 ± 0.4), followed by the cerebellar cortex (4.4 ± 0.2), and others.
  • Although regional differences were small, the observed [<sup>11</sup>C]CB184 binding pattern was consistent with the TSPO distribution in the normal human brain.
  • Radiation dosimetry was determined in three healthy male subjects using a serial whole-body PET scan acquired over 2 h after [<sup>11</sup>C]CB184 injection.
  • [<sup>11</sup>C]CB184 PET demonstrated high uptake in the gallbladder at a later time (>60 min).
  • The absorbed dose (μGy/MBq) was highest in the kidneys (21.0 ± 0.5) followed by the lungs (16.8 ± 2.7), spleen (16.6 ± 6.6), and pancreas (16.5 ± 2.2).
  • The estimated effective dose for [<sup>11</sup>C]CB184 was 5.9 ± 0.6 μSv/MBq.
  • CONCLUSIONS: This initial evaluation indicated that [<sup>11</sup>C]CB184 is feasible for imaging of TSPO in the brain.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Nucl Med Mol Imaging. 2010 Mar;37(3):606-12 [19862517.001]
  • [Cites] Glia. 2002 Nov;40(2):206-17 [12379908.001]
  • [Cites] J Nucl Med. 2014 Dec;55(12 ):1966-72 [25453044.001]
  • [Cites] J Nucl Med. 2015 Apr;56(4):512-7 [25722450.001]
  • [Cites] Drug Discov Today. 2010 Nov;15(21-22):933-42 [20800696.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 Jan;27(1):173-84 [16685259.001]
  • [Cites] J Nucl Med. 2010 Jan;51(1):145-9 [20008980.001]
  • [Cites] J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9 [17519979.001]
  • [Cites] Prog Neurobiol. 2006 Dec;80(6):308-22 [17156911.001]
  • [Cites] FEBS Lett. 2011 Dec 1;585(23):3798-805 [21889505.001]
  • [Cites] J Nucl Med. 1975 Mar;16(3):247-9 [1113178.001]
  • [Cites] Trends Pharmacol Sci. 2006 Aug;27(8):402-9 [16822554.001]
  • [Cites] J Nucl Med. 2005 Jun;46(6):1023-7 [15937315.001]
  • [Cites] J Nucl Med. 2013 Nov;54(11):1915-23 [24071511.001]
  • [Cites] J Nucl Med. 2009 Jul;50(7):1047-53 [19525468.001]
  • [Cites] J Nucl Med. 2009 Aug;50(8):1276-82 [19617321.001]
  • [Cites] Ann Nucl Med. 2016 Oct;30(8):534-43 [27329083.001]
  • [Cites] Bioconjug Chem. 2013 Sep 18;24(9):1415-28 [23837837.001]
  • [Cites] Nucl Med Biol. 2012 Feb;39(2):305-14 [22033023.001]
  • [Cites] J Nucl Med. 2011 Jan;52(1):24-32 [21149489.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):921-31 [23436070.001]
  • [Cites] J Cereb Blood Flow Metab. 2011 Aug;31(8):1807-16 [21522163.001]
  • [Cites] Brain Res Bull. 1987 Jan;18(1):49-61 [3030512.001]
  • [Cites] Curr Pharm Des. 2008;14 (31):3297-315 [19075709.001]
  • [Cites] J Cereb Blood Flow Metab. 2014 Jun;34(6):989-94 [24643083.001]
  • [Cites] Ann Nucl Med. 2015 May;29(4):325-35 [25616581.001]
  • [Cites] Neuroimage. 2011 Jun 1;56(3):1111-21 [21320609.001]
  • [Cites] Sci Rep. 2016 Feb 08;6:20422 [26853260.001]
  • [Cites] Neuroimage. 2008 Mar 1;40(1):43-52 [18093844.001]
  • [Cites] Australas Phys Eng Sci Med. 2016 Mar;39(1):177-86 [26728881.001]
  • [Cites] Nat Rev Neurol. 2010 Apr;6(4):193-201 [20234358.001]
  • [Cites] Nucl Med Biol. 2014 Nov-Dec;41(10):871-5 [25156039.001]
  • [Cites] Theranostics. 2015 May 26;5(9):961-9 [26155312.001]
  • [Cites] Trends Neurosci. 1996 Aug;19(8):312-8 [8843599.001]
  • [Cites] Int Rev Neurobiol. 2011;101:19-39 [22050847.001]
  • [Cites] Nucl Med Biol. 2012 May;39(4):570-8 [22172392.001]
  • [Cites] J Nucl Med. 2013 Aug;54(8):1302-7 [23804329.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2015 Jun;42(7):1106-18 [25771904.001]
  • [Cites] J Nucl Med. 2007 Dec;48(12 ):2072-9 [18006619.001]
  • (PMID = 28337723.001).
  • [Journal-full-title] EJNMMI research
  • [ISO-abbreviation] EJNMMI Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


8. Chandrasekhar J, Dangas G, Yu J, Vemulapalli S, Suchindran S, Vora AN, Baber U, Mehran R, STS/ACC TVT Registry: Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014. J Am Coll Cardiol; 2016 Dec 27;68(25):2733-2744

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sex-Based Differences in Outcomes With Transcatheter Aortic Valve Therapy: TVT Registry From 2011 to 2014.
  • RESULTS: From 2011 to 2014, a total of 11,808 (49.9%) women and 11,844 (51.1%) men underwent TAVR.
  • Compared with male patients, female patients were older, with a lower prevalence of coronary artery disease, atrial fibrillation, and diabetes but a higher rate of porcelain aorta, lower glomerular filtration rate, and higher mean Society of Thoracic Surgeons score (9.0% vs. 8.0%; all p < 0.001).
  • In-hospital vascular complications were higher in women (8.27% vs. 4.39%; adjusted hazard ratio [HR]: 1.70; 95% CI: 1.34 to 2.14; p < 0.001) and a trend toward higher bleeding (8.01% vs 5.96%; adjusted HR: 1.19; 95% CI: 0.99 to 1.44; p = 0.06) was observed; however, 1-year mortality was lower (21.3% vs. 24.5%; adjusted HR: 0.73; 95% CI: 0.63 to 0.85; p < 0.001) in women than in men.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
  • (PMID = 28007135.001).
  • [ISSN] 1558-3597
  • [Journal-full-title] Journal of the American College of Cardiology
  • [ISO-abbreviation] J. Am. Coll. Cardiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; long-term outcomes / sex-based differences / transcatheter aortic valve replacement
  •  go-up   go-down


9. Parker WP, Evans JD, Stish BJ, Park SS, Olivier K, Choo R, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ, Davis BJ: Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys; 2017 Mar 01;97(3):526-535

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography.
  • PURPOSE: To evaluate C-11 choline positron emission tomography/computed tomography (CholPET) in staging and determining patterns of recurrence in prostate cancer patients with rising prostate-specific antigen levels after prostatectomy radiation therapy (RT).
  • Median interval from RT to biochemical failure was 24 (IQR, 10-46) months, with recurrence identified on CholPET at a median of 15 (IQR, 7-28) months from biochemical failure.
  • Five patients (12%) had IF recurrences, 10 patients (24%) had EOF recurrences (median dose 10 Gy; IQR, 5-30 Gy), and 36 patients (88%) had OOF recurrences.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 Elsevier Inc. All rights reserved.
  • [Cites] Eur Urol. 2015 Feb;67(2):299-309 [24571959.001]
  • [Cites] Cancer. 2008 Jan 15;112(2):307-14 [18050294.001]
  • [Cites] Eur Urol. 2014 Aug;66(2):243-50 [24680359.001]
  • [Cites] Eur Urol. 2017 Mar;71(3):340-348 [27597240.001]
  • [Cites] J Urol. 2015 Dec;194(6):1624-30 [26165583.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1971-9 [27277279.001]
  • [Cites] Eur Urol. 2014 May;65(5):947-64 [23957947.001]
  • [Cites] J Clin Oncol. 2007 May 20;25(15):2035-41 [17513807.001]
  • [Cites] Urol Oncol. 2017 Mar;35(3):122-123 [28159496.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):361-8 [19394158.001]
  • [Cites] J Clin Oncol. 2008 Mar 1;26(7):1148-59 [18309951.001]
  • [Cites] Urology. 2003 Mar;61(3):607-11 [12639656.001]
  • [Cites] J Urol. 2013 Apr;189(4):1308-13 [23123372.001]
  • [Cites] Cancer Radiother. 2014 Oct;18(5-6):524-34 [25192626.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):822-8 [23845839.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):301-9 [19756592.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):29-35 [19467803.001]
  • [Cites] BJU Int. 2008 Aug;102(4):446-51 [18410442.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):383-7 [18947938.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):425-30 [17881141.001]
  • [Cites] Cancer. 2015 Jul 15;121(14):2350-7 [25809861.001]
  • [Cites] BJU Int. 2017 Mar;119(3):406-413 [27104782.001]
  • [Cites] Eur Urol. 2013 Jul;64(1):106-17 [23628493.001]
  • [Cites] J Clin Oncol. 2014 Dec 10;32(35):3939-47 [25245445.001]
  • [Cites] Eur Urol. 2016 Dec;70(6):926-937 [27363387.001]
  • [Cites] Cancer. 2009 Jun 1;115(11):2388-99 [19399748.001]
  • [Cites] J Clin Oncol. 2016 Aug 1;:null [27480153.001]
  • [Cites] Eur Urol. 2014 Feb;65(2):467-79 [24321502.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1270-9 [24599378.001]
  • [Cites] Eur Urol. 2011 May;59(5):832-40 [21354694.001]
  • [Cites] J Urol. 2009 Mar;181(3):956-62 [19167731.001]
  • [Cites] J Urol. 2015 Jan;193(1):111-6 [25150640.001]
  • [Cites] Radiother Oncol. 2009 Nov;93(2):207-12 [19766338.001]
  • [Cites] Ann Surg Oncol. 2010 Jun;17(6):1471-4 [20180029.001]
  • [Cites] J Urol. 2001 Apr;165(4):1146-51 [11257657.001]
  • [Cites] Lancet. 2005 Aug 13-19;366(9485):572-8 [16099293.001]
  • [Cites] J Nucl Med. 2015 Aug;56(8):1185-90 [26112024.001]
  • [Cites] J Natl Compr Canc Netw. 2016 Jan;14 (1):19-30 [26733552.001]
  • [Cites] Radiat Oncol. 2011 May 01;6:44 [21529377.001]
  • [Cites] Eur Urol. 2015 Nov;68(5):777-84 [25959166.001]
  • [Cites] J Nucl Med. 2014 Feb;55(2):223-32 [24434294.001]
  • [Cites] BMC Cancer. 2015 Sep 25;15:646 [26408012.001]
  • [Cites] Eur Urol. 2011 Nov;60(5):935-43 [21840116.001]
  • (PMID = 28126302.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA200551
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. DeForte S, Uversky VN: Quarterly intrinsic disorder digest (April-May-June, 2014). Intrinsically Disord Proteins; 2017;5(1):e1287505

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Quarterly intrinsic disorder digest (April-May-June, 2014).
  • The current digest issue covers papers published during the second quarter of 2014; i.e., during the period of April, May, and June of 2014.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Immunol Methods. 2014 May;407:90-107 [24726865.001]
  • [Cites] Biophys J. 2014 Apr 15;106(8):1638-49 [24739163.001]
  • [Cites] Proc Natl Acad Sci U S A. 2014 May 27;111(21):7671-6 [24817693.001]
  • [Cites] Phys Chem Chem Phys. 2014 Apr 14;16(14):6323-31 [24317797.001]
  • [Cites] Biochemistry. 2014 Apr 29;53(16):2739-48 [24720254.001]
  • [Cites] Biochim Biophys Acta. 2014 Jun;1840(6):2050-9 [24576674.001]
  • [Cites] Biophys J. 2014 Apr 15;106(8):1771-9 [24739176.001]
  • [Cites] Biophys J. 2014 May 20;106(10):2184-95 [24853747.001]
  • [Cites] J Biosci. 2014 Apr;39(2):281-302 [24736160.001]
  • [Cites] Biophys Chem. 2014 May;189:33-9 [24747333.001]
  • [Cites] Proteins. 2014 Apr;82(4):657-67 [24123297.001]
  • [Cites] Protein Sci. 2014 May;23(5):539-50 [24532081.001]
  • [Cites] J Phys Chem B. 2014 Apr 17;118(15):4088-97 [24673507.001]
  • [Cites] J Biol Chem. 2014 May 16;289(20):13903-11 [24634216.001]
  • [Cites] Mol Biosyst. 2014 Jun;10(6):1469-80 [24668165.001]
  • [Cites] Intrinsically Disord Proteins. 2014 May 19;2(1):e27833 [28232877.001]
  • [Cites] Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6311-6 [24733915.001]
  • [Cites] Phys Rev Lett. 2014 Apr 18;112(15):158103 [24785077.001]
  • [Cites] J Am Chem Soc. 2014 Jun 18;136(24):8708-13 [24844314.001]
  • [Cites] J Proteome Res. 2014 Jun 6;13(6):2735-48 [24754740.001]
  • [Cites] Proteins. 2014 Apr;82(4):565-78 [24115198.001]
  • [Cites] Chem Commun (Camb). 2014 May 25;50(40):5245-7 [24022511.001]
  • [Cites] Science. 2014 May 9;344(6184):1250494 [24812405.001]
  • [Cites] Bioinformatics. 2014 Jun 1;30(11):1601-8 [24493033.001]
  • [Cites] Biopolymers. 2014 Jun;101(6):591-602 [24122746.001]
  • [Cites] Amino Acids. 2014 Apr;46(4):853-62 [24363213.001]
  • [Cites] J Immunol Methods. 2014 Apr;406:83-103 [24614036.001]
  • [Cites] J Am Chem Soc. 2014 May 14;136(19):6987-94 [24758710.001]
  • [Cites] J Biol Chem. 2014 Jun 20;289(25):17325-37 [24795046.001]
  • [Cites] J Magn Reson. 2014 Apr;241:155-69 [24120537.001]
  • [Cites] Biophys J. 2014 Jun 17;106(12):2644-55 [24940782.001]
  • [Cites] ChemistryOpen. 2014 Jun;3(3):115-23 [25050230.001]
  • [Cites] Matrix Biol. 2014 Jun;36:77-83 [24810542.001]
  • [Cites] Intrinsically Disord Proteins. 2016 Feb 12;4(1):e1153395 [28232896.001]
  • [Cites] Structure. 2014 Jun 10;22(6):854-65 [24768114.001]
  • [Cites] Biomol NMR Assign. 2014 Apr;8(1):141-4 [23417771.001]
  • [Cites] Protein Pept Lett. 2014 May;21(5):452-7 [24330085.001]
  • [Cites] Curr Opin Virol. 2014 Apr;5:72-81 [24631901.001]
  • [Cites] Curr Biol. 2014 Jun 16;24(12):1295-303 [24835459.001]
  • [Cites] Autophagy. 2014 Jun;10 (6):1093-104 [24879155.001]
  • [Cites] J Magn Reson. 2014 Apr;241:74-85 [24656082.001]
  • [Cites] Mol Genet Genomics. 2014 Jun;289(3):317-32 [24442277.001]
  • [Cites] Mol Biosyst. 2014 Jun;10(6):1345-63 [24752801.001]
  • [Cites] Biochem Biophys Res Commun. 2014 May 16;447(4):633-7 [24751520.001]
  • [Cites] Proteins. 2014 Apr;82(4):668-78 [24150971.001]
  • [Cites] J Phys Chem B. 2014 Jun 19;118(24):6405-16 [24410358.001]
  • [Cites] FEBS J. 2014 Jun;281(12):2738-53 [24725464.001]
  • [Cites] Cell Mol Life Sci. 2014 Apr;71(8):1477-504 [23942625.001]
  • [Cites] Biophys J. 2014 Jun 3;106(11):2474-82 [24896127.001]
  • [Cites] J Magn Reson. 2014 Apr;241:97-102 [24360766.001]
  • [Cites] Matrix Biol. 2014 Apr;35:73-81 [24246365.001]
  • [Cites] ACS Chem Biol. 2014 Apr 18;9(4):891-6 [24437616.001]
  • [Cites] Biophys J. 2014 Apr 15;106(8):1751-62 [24739174.001]
  • [Cites] Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4874-9 [24639500.001]
  • [Cites] Mol Endocrinol. 2014 May;28(5):768-77 [24678734.001]
  • [Cites] Angew Chem Int Ed Engl. 2014 Apr 7;53(15):3840-3 [24604825.001]
  • [Cites] J Magn Reson. 2014 Apr;241:41-52 [24656079.001]
  • [Cites] J Magn Reson. 2014 Apr;241:115-25 [24656084.001]
  • [Cites] J Biol Chem. 2014 Apr 4;289(14):10057-68 [24550393.001]
  • [Cites] Curr Opin Struct Biol. 2014 Jun;26:62-72 [24930020.001]
  • [Cites] Epigenetics. 2014 Jun;9(6):791-7 [24622397.001]
  • [Cites] Biopolymers. 2014 May;101(5):525-35 [24114119.001]
  • [Cites] Phys Chem Chem Phys. 2014 Apr 14;16(14 ):6480-5 [24605363.001]
  • [Cites] J Mol Biol. 2014 May 15;426(10 ):2082-97 [24650897.001]
  • [Cites] J Am Chem Soc. 2014 May 14;136(19):7068-76 [24734879.001]
  • [Cites] Nucleic Acids Res. 2014 Apr;42(6):3503-14 [24435799.001]
  • [Cites] Nature. 2014 Apr 17;508(7496):331-9 [24740064.001]
  • [Cites] FEBS Lett. 2014 May 2;588(9):1839-49 [24717772.001]
  • [Cites] Biomol NMR Assign. 2014 Apr;8(1):123-7 [23339032.001]
  • [Cites] J Cell Sci. 2014 Jun 1;127(Pt 11):2460-70 [24652833.001]
  • [Cites] J Am Chem Soc. 2014 Apr 9;136(14):5197-200 [24654952.001]
  • [Cites] Phys Chem Chem Phys. 2014 Apr 14;16(14):6342-57 [24469063.001]
  • [Cites] Biochim Biophys Acta. 2014 Jun;1844(6):1153-66 [24704038.001]
  • [Cites] Biochim Biophys Acta. 2014 Apr;1844(4):837-49 [24590112.001]
  • [Cites] J Phys Chem B. 2014 Apr 3;118(13):3532-42 [24490961.001]
  • [Cites] J Biomol NMR. 2014 May;59(1):43-50 [24699834.001]
  • [Cites] Biochemistry. 2014 May 6;53(17):2815-7 [24739028.001]
  • [Cites] Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5213-8 [24706910.001]
  • [Cites] J Struct Biol. 2014 Jun;186(3):431-7 [24657229.001]
  • [Cites] J Chem Phys. 2014 May 7;140(17 ):175102 [24811666.001]
  • [Cites] RNA Biol. 2014;11(4):298-312 [24643059.001]
  • (PMID = 28321370.001).
  • [ISSN] 2169-0693
  • [Journal-full-title] Intrinsically disordered proteins
  • [ISO-abbreviation] Intrinsically Disord Proteins
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; database / intrinsically disordered proteins / protein function / structural ensemble / structural proteins
  •  go-up   go-down